JP5371068B2 - メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法 - Google Patents

メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法 Download PDF

Info

Publication number
JP5371068B2
JP5371068B2 JP2011540605A JP2011540605A JP5371068B2 JP 5371068 B2 JP5371068 B2 JP 5371068B2 JP 2011540605 A JP2011540605 A JP 2011540605A JP 2011540605 A JP2011540605 A JP 2011540605A JP 5371068 B2 JP5371068 B2 JP 5371068B2
Authority
JP
Japan
Prior art keywords
metformin
hydroxypropylcellulose
solution
hydroxypropyl cellulose
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011540605A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012511568A (ja
Inventor
ファン チョ，イル
キ ホン，イル
クン アン，テ
テク リー，ヨン
オー チョン，セオン
シク ユン，ミョン
エク クウォン，オー
ボム リー，シ
ウォン オー，ダ
ヒュン チョイ，ナク
チョン リー，ヘー
ジュン ノー，ヒュン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ CheilJedang Corp
Original Assignee
CJ CheilJedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CJ CheilJedang Corp filed Critical CJ CheilJedang Corp
Publication of JP2012511568A publication Critical patent/JP2012511568A/ja
Application granted granted Critical
Publication of JP5371068B2 publication Critical patent/JP5371068B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011540605A 2008-12-15 2009-12-10 メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法 Expired - Fee Related JP5371068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2008-0127289 2008-12-15
KR1020080127289A KR101189639B1 (ko) 2008-12-15 2008-12-15 메트포르민 및 α-글리코시다제 억제제를 포함하는 경구 제제 및 그 제조방법
PCT/KR2009/007383 WO2010071321A2 (ko) 2008-12-15 2009-12-10 메트포르민 및 α-글리코시다제 억제제를 포함하는 경구 제제 및 그 제조방법

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013118910A Division JP5671767B2 (ja) 2008-12-15 2013-06-05 メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法

Publications (2)

Publication Number Publication Date
JP2012511568A JP2012511568A (ja) 2012-05-24
JP5371068B2 true JP5371068B2 (ja) 2013-12-18

Family

ID=42269214

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011540605A Expired - Fee Related JP5371068B2 (ja) 2008-12-15 2009-12-10 メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法
JP2013118910A Expired - Fee Related JP5671767B2 (ja) 2008-12-15 2013-06-05 メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013118910A Expired - Fee Related JP5671767B2 (ja) 2008-12-15 2013-06-05 メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法

Country Status (4)

Country Link
JP (2) JP5371068B2 (zh)
KR (1) KR101189639B1 (zh)
CN (2) CN102245172B (zh)
WO (1) WO2010071321A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101336499B1 (ko) * 2013-03-06 2013-12-03 씨제이제일제당 (주) 당뇨병의 예방 또는 치료용 복합 조성물
US20200164047A1 (en) * 2017-05-19 2020-05-28 Università Degli Studi Di Milano Therapy and diagnosis of disease characterized by alterations in the dna damage response
CN111374952B (zh) * 2018-12-29 2022-07-26 甘李药业江苏有限公司 阿卡波糖药物组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
WO2006080630A1 (en) * 2004-09-23 2006-08-03 Handok Pharmaceuticals Co., Ltd. Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Also Published As

Publication number Publication date
WO2010071321A3 (ko) 2010-10-21
CN103143018A (zh) 2013-06-12
JP2013189466A (ja) 2013-09-26
KR101189639B1 (ko) 2012-10-12
WO2010071321A2 (ko) 2010-06-24
JP2012511568A (ja) 2012-05-24
JP5671767B2 (ja) 2015-02-18
CN102245172B (zh) 2013-04-10
KR20100068811A (ko) 2010-06-24
CN102245172A (zh) 2011-11-16

Similar Documents

Publication Publication Date Title
CN110787145B (zh) 一种枸橼酸托法替布缓释片及其制备方法
TWI483943B (zh) 醫藥組合物、醫藥劑型、其製備方法及其用途
US8551524B2 (en) Anti-diabetic combinations
CN101094657B (zh) 用于糖尿病药物的口服给药的控释复合制剂及其制备方法
US20120041069A1 (en) Sglt2 inhibitor dosage forms
BR112020024271A2 (pt) combinação farmacêutica, composição e preparação de composto contendo ativador de glucoquinase e bloqueador de canal k-atp, método de preparação dos mesmos e uso dos mesmos
CA2681092A1 (en) Anti-diabetic combinations comprising a slow release biguanide composition and an immediate release dipeptidyl peptidase iv inhibitor composition
KR20160111237A (ko) 메트포르민 및 시타글립틴을 포함하는 경구용 복합제제
JP2023026623A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む、優れた溶解特性を備えた薬学的製剤
WO2004054574A1 (ja) 経口固形医薬
WO2021238978A1 (zh) 含硝羟喹啉前药的药物组合物及其制备方法和应用
CN105878204A (zh) 一种盐酸二甲双胍渗透泵控释片及其制备方法
CN103181923B (zh) 包含瑞格列奈的药物制剂及其制备方法
JP5671767B2 (ja) メトホルミンおよびα−グリコシダーゼ抑制剤を含む経口製剤、およびその製造方法
KR20060096728A (ko) 서방성 펠렛을 포함하는 서방성 제제 및 복합 서방성 정제
CN111329841B (zh) 格列齐特缓释片及其制备方法
EP3025707A1 (en) A multilayer tablet comprising metformin and pioglitazone
KR20210003786A (ko) 당뇨병의 치료에서 사용하기 위한 트리아진 유도체를 포함하는 필름 코팅정
KR100531612B1 (ko) 지속성 탐스로신 정제의 제조방법 및 그에 따른 지속성탐스로신 정제
KR102573842B1 (ko) 방출특성이 우수한 에스오메프라졸 및 탄산수소나트륨의 약제학적 조성물
CN107913259A (zh) 一种盐酸二甲双胍控释片及其制备方法
KR20210012881A (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 우수한 방출특성을 갖는 약제학적 제제
CN104434856A (zh) 一种胃漂浮型格列吡嗪控释片及其制备工艺
KR102362342B1 (ko) 빌다글립틴 및 메트포민 포함하는 복합 정제
CN102949406A (zh) 一种复方艾夫他滨药物组合物及其制备方法和用途

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130430

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130509

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130605

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130905

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130912

R150 Certificate of patent or registration of utility model

Ref document number: 5371068

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees